References
- Archdeacon, P., Chan, M., Neulan, C., Velidedeoglu, E., Meyer, J., Tracy, L., Cavaille-Coll, M., Bala, S., Hernandez, A., Allbercht, R. (2011). Summary of FDA Antibody-Mediated Rejection Workshop. Amer. J. Transplant., 11 (5), 896–906.
- Chkhotua A. B., Klein, T., Shabtai, E., Yussim, A., Bar-Nathan, N., Shaharabani, E., Lustig, S., Mor, E. (2003). Kidney transplantation from living-unrelated donors: Comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. Urology, 62 (6), 1002–1006.
- Clayton, P. A., McDonald, S. P., Russ, G. R., Chadban, S. J. (2019). Long-term outcomes after acute rejection in kidney transplant recipients: An ANZDATA analysis. J. Amer. Soc. Nephrol., 30 (9), 1697–1707.
- EGFR Calculator. (n.d.). National Kidney Foundation. https://www.kidney.org/professionals/kdoqi/gfr_calculator (accessed 09.07.2024).
- Farkash, E. A., Robert, B. C. (2012). Diagnostic challenges in chronic anrtibody-mediated rejection. Nat. Rev. Nephrol., 8 (5), 255–257.
- Foroutan, F., Friesen, E. L., Clark, K. E., Motaghi, S., Zyla, R., Lee, Y., Kamran, R., Ali, E., Snoo, M. D., Orchanian-Cheff, A., Ribic, C., Treleaven, D. J., Guyatt, G., O Meade, M. (2019). Risk factors for 1-year graft loss after kidney transplantation. Clin. J. Amer. Soc. Nephrol., 14 (11), 1642–1650.
- Gaston, R. S., Cecka, M. J., Kasiske, B. L., Fieberg, A. M., Leduc, R., Cosio, F. C., Gourishankar, S., Grande, J., Halloran, P., Hunsicker, L., Mannon, R., Rush, D., Matas, A. J. (2010). Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation, 90 (1), 68–74.
- Gowrishankar, S. (2022). Banff classification from 1991 to 2019. A significant contribution to our understanding and reporting of allograft renal biopsies. Indian. J. Nephrol., 32 (1), 1–7.
- Gupta, S., Gea-Banacloche, J., Heilman, R. L., Yaman, R. N., Me Me, H., Zhang, N., Vikram, H. R., Kodali, L. (2024). Impact of early rejection treatment on infection development in kidney transplant recipients: A propensity analysis. J. Transplant., 6663086.
- Hara S. (2017). Current pathological perspectives on chronic rejection ion renal allografts. Clin. Exp. Nephrol., 21 (6), 943–951.
- Hucker, A., Bunn, F., Carpenter, L., Lawrence C., Farrington, K., Sharma, S. (2017). Non-adherence to immunosuppressants following renal transplantation: A protocol for systematic review. BMJ Open, 7 (9), e015411.
- Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009). KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Amer. J. Transplant., Suppl. 3, S1–155.
- Lentine, K. L., Smith, J. M., Lyden, G. R., Miller, J. M., Dolans, T. G., Bradbrook, K., Larkin, L., Temple, K., Handarova, Dz. K., Weiss, S., Israni, A. K., Snyder, J. J. (2024). OPTN/SRTR 2022 Annual Data Report: Kidney. Amer. J. Transplant., 24 (2S1), S19–S118.
- Loghman-Adham, M. Medication noncompliance in patients with chronic disease: Issues in dialysis and renal transplantation. (2003). Amer. J. Manag. Care, 9 (2), 155–171.
- Mateu, L. M. P., Calabuig, A. S., Plaza, L. C., Esteve, A. F. (2004). Acute rejection and late renal transplant failure: Risk factors and prognosis. Nephrol. Dial. Transplant., Suppl 3, iii38–42.
- Oweira, H., Ramouz, A., Ghamarnejad, O., Khajeh, E., Ali-Hasan-Al-Saegh, S., Nikbakhsh, R., Reißfelder, C., Rahbari, N., Mehrabi, A., Sadeghi, M. (2022). Risk factors of rejection in renal transplant recipients: A narrative review. J. Clin. Med., 11 (5), 1392.
- Perrottet, N., Fernández-Ruiz, M., Binet, I., Dickenmann, M., Dahdal, S., Hadaya, K., Müller, T., Schaub, S., Koller, M., Rotman, S., et al. (2021). Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study. PLoS One, 16 (4), e0250829.
- Poggio, E. D., Augustine, J. J., Arrigain, S., Brennan, D. C., Schold, J. D. (2021). Long-term kidney transplant graft survival: Making progress when most needed. Amer. J. Transplant., 21 (8), 2824–2832.
- Roufosse, C., Simmonds, N., Clahsen-van Groningen, M., Haas, M., Henriksen K. J., Horsfield, C., Loupy, A., Mengel, M., Perkowska-Ptasinska A., Rabant, M., Racusen, L. C., Solez, K., Becker, J. U. (2018). A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation, 102 (11), 1795–1814.
- Santos Jr., A. H., Casey, M. J., Womer, K. L. (2017). Analysis of risk factors for kidney retransplant outcomes associated with common induction regiments: A study of over twelve-thousand cases in the United States. J. Trasnplant., 8132672.
- Schinstock, C. A., Mannon, R. B., Budde, K., Chong, A. S., Haas, M., Knechtle, S., Lefaucher, C., Montgomery, R. A., Nickerson, P., Tullius, S. G., et al. (2020). Recommended treatment for antibody-mediated rejection after kidney transplantation: The 2019 Expert Consensus From the Transplantation Society Working Group. Transplantation, 104 (5), 911–922.
- Sellarés, J., de Freitas, D. G., Mengel, M., Reeve, J., Einecke, G., Sis, B., Hidalgo, L. G., Famulski, K., Matas, A., Halloran, P. F. (2012). Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Amer. J. Transplant., 12 (2), 388–399.
- Tonelli, M., Wiebe, N., Knoll, G., Bello, A., Browne, S., Jadhav, D., Klarenbach, S., Gill, J. (2011). Systematic Review: Kidney transplantation compared with dialysis in cinically relevant outcomes. Amer. J. Transplant., 11 (10), 2093–109.
- Velidedeoglu, E., V., Cavaillé-Coll, M. W., Shukal, B., Ozlem, A. B., Wang, Y., Albrecht, R. (2018). Summary of 2017 FDA Public Workshop: Antibody-mediated rejection in kidney transplantation. Transplantation, 102 (6), e257–e264.
- Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y., Held, P. J., Port, F. K. (1999). Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl. J. Med., 341 (23), 1725-1730.